238 related articles for article (PubMed ID: 33262559)
1. A critical analysis of CTRI registered AYUSH studies for COVID- 19.
Bhapkar V; Sawant T; Bhalerao S
J Ayurveda Integr Med; 2022; 13(1):100370. PubMed ID: 33262559
[TBL] [Abstract][Full Text] [Related]
2. A methodological analysis of CTRI registered clinical trials on ayurveda interventions for COVID-19 management.
Chaudhari SS; Somvanshi PR
J Ayurveda Integr Med; 2023; 14(1):100631. PubMed ID: 35971456
[TBL] [Abstract][Full Text] [Related]
3. Analysis of AYUSH studies registered in clinical trials registry of India from 2009 to 2020.
Shree Devi MS; Sathiyarajeswaran P; Kanakavalli K; Vinod NP; Baskar V
J Ayurveda Integr Med; 2021; 12(2):346-350. PubMed ID: 34024689
[TBL] [Abstract][Full Text] [Related]
4. A Systematic Analysis of COVID-19 Clinical Trials Registered in the Clinical Trials Registry of India.
Dutta S; Singhal S; Shah R
Cureus; 2024 Apr; 16(4):e57939. PubMed ID: 38738059
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of COVID-19 Studies Registered with the Clinical Trials Registry of India [CTRI] - A database Analysis.
Vl C; Cj G; Sr B; Nn D; Nj G; Um T
J Assoc Physicians India; 2021 Oct; 69(10):11-12. PubMed ID: 34781650
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of Ayurvedic interventions and Yoga on long term effects of COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Yadav B; Rai A; Mundada PS; Singhal R; Rao BCS; Rana R; Srikanth N
Trials; 2021 Jun; 22(1):378. PubMed ID: 34082792
[TBL] [Abstract][Full Text] [Related]
7. In search for a panacea for coronavirus disease-19: Analysis of ongoing clinical trials for the management of coronavirus disease-19 pandemic in India.
Maheshwari N; Roy V
Indian J Pharmacol; 2022; 54(4):258-269. PubMed ID: 36204809
[TBL] [Abstract][Full Text] [Related]
8. Snapshot of COVID-19 Related Clinical Trials in India.
Charan J; Kaur R; Bhardwaj P; Kanchan T; Mitra P; Yadav D; Sharma P; Misra S
Indian J Clin Biochem; 2020 Oct; 35(4):418-422. PubMed ID: 32837035
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of herbal extracts to restore respiratory health and improve innate immunity in COVID-19 positive patients with mild to moderate severity: A structured summary of a study protocol for a randomised controlled trial.
Rangnekar H; Patankar S; Suryawanshi K; Soni P
Trials; 2020 Nov; 21(1):943. PubMed ID: 33225970
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic clinical trials to combat COVID-19 pandemic in India: analysis from trial registry.
Batta A; Khirasaria R; Kapoor V; Varshney D
J Basic Clin Physiol Pharmacol; 2020 Dec; 32(3):267-278. PubMed ID: 33578506
[TBL] [Abstract][Full Text] [Related]
11. Association between Usage of Prophylactic AYUSH Medicines and Disease Severity in COVID-19 Patients: A Retrospective Cohort Study.
Chaudhary A; Nayak D; Pandey S; Shastri V; Kamble M; Pendse V; Prajapati V; Vaidya B; Rohit H; Beedmani S; Presswala N; Patole T; Bawaskar R; Shinde V; Datta M; Rai G; Prusty U; Pal PP; Goli SP; Sahoo AR; Muraleedharan KC; Prakash P; Mahajan A; Singh A; Krishnan R; Pawaskar N; Srivastava A; Ningthoujam GD; Sadarla RK; Sonny R; Karso L; Sarkar S; Prasad S; Shrivastava AK; Kumar A; Kumar N; Raveendar C; Kumar BR; Sastry V; Dasari A; Sundeep KS; Kaushik S; Rath P; Gautam S; Shil RC; Swain TL; Reddy GRC; Pradeep S; Stevenson S; Choubey G; Debata L; Khurana A
Homeopathy; 2024 May; ():. PubMed ID: 38714214
[TBL] [Abstract][Full Text] [Related]
12. Impact of AYUSH interventions on COVID-19: a protocol for a living systematic review and meta-analysis.
Thakar A; Panara K; Goyal M; Kumari R; Sungchol K
F1000Res; 2021; 10():674. PubMed ID: 35186267
[No Abstract] [Full Text] [Related]
13. Mobile App-Reported Use of Traditional Medicine for Maintenance of Health in India During the COVID-19 Pandemic: Cross-sectional Questionnaire Study.
Srikanth N; Rana R; Singhal R; Jameela S; Singh R; Khanduri S; Tripathi A; Goel S; Chhatre L; Chandra A; Rao BCS; Dhiman KS
JMIRx Med; 2021; 2(2):e25703. PubMed ID: 34032815
[TBL] [Abstract][Full Text] [Related]
14. AYUSH-64 as an add-on to standard care in asymptomatic and mild cases of COVID-19: A randomized controlled trial.
Reddy RG; Gosavi RV; Yadav B; Rai AK; Holay MP; Talekar M; Jameela S; Sharma BS; Khanduri S; Rana R; Tripathi A; Chandrasekhararao B; Srikanth N; Dhiman KS
Ayu; 2020; 41(2):107-116. PubMed ID: 34908795
[TBL] [Abstract][Full Text] [Related]
15. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
16. Can Guduchi (Tinospora cordifolia), a well-known ayurvedic hepato-protectant cause liver damage?
Panneer Selvam K; Payyappallimana U; Ravikumar K; Venkatasubramanian P
J Ayurveda Integr Med; 2023; 14(1):100658. PubMed ID: 36400639
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of Siddha Medicine, Kabasura Kudineer (KSK) compared to Vitamin C & Zinc (CZ) supplementation in the management of asymptomatic COVID-19 cases: A structured summary of a study protocol for a randomised controlled trial.
Natarajan S; Anbarasi C; Sathiyarajeswaran P; Manickam P; Geetha S; Kathiravan R; Prathiba P; Pitchiahkumar M; Parthiban P; Kanakavalli K; Balaji P
Trials; 2020 Oct; 21(1):892. PubMed ID: 33109252
[TBL] [Abstract][Full Text] [Related]
18. Disease Characteristics, Care-Seeking Behavior, and Outcomes Associated With the Use of AYUSH-64 in COVID-19 Patients in Home Isolation in India: A Community-Based Cross-Sectional Analysis.
Srikanth N; Kumar A; Chandrasekhararao B; Singhal R; Yadav B; Khanduri S; Jameela S; Rai AK; Tripathi A; Rana R; Ahmad A; Sharma BS; Jaiswal A; Kotecha R;
Front Public Health; 2022; 10():904279. PubMed ID: 35900336
[TBL] [Abstract][Full Text] [Related]
19. Overview of
Adhikari T; Rao MVV; Srikanth N; Juneja A; Sharma S; Maulik M; Gupta J; Panchal Y; Rao BCS; Khanduri S; Narayan RV; Bhardwaj R; Batra P
Ayu; 2020; 41(3):143-147. PubMed ID: 35370375
[TBL] [Abstract][Full Text] [Related]
20. AYUSH- 64: A potential therapeutic agent in COVID-19.
Panda AK; Kar S; Rai AK; Rao BCS; Srikanth N
J Ayurveda Integr Med; 2022; 13(2):100538. PubMed ID: 35002178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
